Latest news with #DietmarSiemssen
Yahoo
7 days ago
- Business
- Yahoo
Gerresheimer to spin off moulded glass business
Gerresheimer has announced plans to separate its moulded glass business following a comprehensive strategic review aimed at assessing growth opportunities and competitive positioning. The company, which serves the pharmaceutical, biotech, and cosmetic sectors, plans to initiate a sales process for this business unit. The moulded glass division, strengthened by the acquisition of Bormioli Pharma, operates eight production facilities across the Americas, Europe, and Asia. In 2024, this unit generated approximately €735m ($850.4m) in revenues, with an adjusted earnings before interest, taxes, depreciation, and amortisation margin of around 20%. As part of the integration of Bormioli Pharma, Gerresheimer is establishing the moulded glass business as a standalone entity. Further updates on this transition will be shared during the upcoming capital markets day scheduled for 15 October 2025. The combined operations provide a diverse range of glass packaging solutions, including bottles, jars, and containers, for the pharmaceutical, cosmetic, and food and beverage sectors. In addition, the acquisition has allowed Gerresheimer to expand its offerings, including primary packaging and dosing systems for pharmaceuticals while enhancing opportunities for integrating high-value plastic solutions within the industry. Gerresheimer CEO Dietmar Siemssen said: 'We see the best growth opportunities for our newly formed Moulded Glass Powerhouse outside the Gerresheimer Group. 'As part of our strategic transformation, Gerresheimer will focus even stronger on the portfolio of systems and solutions for the pharma and biotech industry.' The company has invested around €100m in upgrading its facility in Lohr am Main, Germany, by installing an energy-efficient oxy-hybrid furnace over the past two years. In December 2024, Gerresheimer announced the addition of a new syringe production hall at its site in Skopje, North Macedonia, with an investment of more than €100m. "Gerresheimer to spin off moulded glass business" was originally created and published by Packaging Gateway, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Reuters
7 days ago
- Business
- Reuters
Gerresheimer shares rise on plan to sell moulded glass business
Aug 5 (Reuters) - Shares of German packaging and medical equipment maker Gerresheimer ( opens new tab jumped around 4% in early trading on Tuesday after the company announced plans to sell its moulded glass business late on Monday. Gerresheimer had been undertaking a "strategic review" of the unit since 2024 and said it will now begin the separation process immediately. "We see the best growth opportunities for our newly formed moulded glass powerhouse outside the Gerresheimer Group," Gerresheimers' Chief Executive Dietmar Siemssen said in a statement. The decision comes after activist Asset Value Investor published an open letter in June in which it urged the company to take steps to improve its business. Those steps included potentially divesting its moulded glass business, a move supported by two other top-30 investors. The moulded glass business produces glass packaging for the food and beverage and cosmetic industry. "In our view, this is the right move, as it will give Gerresheimer a better growth and margin profile," Christian Reindl, Portfolio manager at Union Investment, said. Union Investment was among the investors that welcomed a divestment of the moulded glass business. Reindl added that shares of the packaging maker are heavily shorted likely because hedge funds are betting on a capital increase. The sale would significantly reduce debt and make a capital increase very unlikely, he said. Gerresheimer, which makes rounded jars for creams and roll-on bottles for deodorants, had issued its first guidance cut, opens new tab of the year a few days prior to the letter. Ongoing low demand in the cosmetics and oral liquids markets led to a second guidance cut in July. With the split, the company now wants to transform into a "pure-play system and solution provider for the pharma and biotech industry". Gerresheimer already makes pens used to inject weight loss drugs such as Novo Nordisk's ( opens new tab Wegovy. The company said it will provide further updates at its Capital Markets Day on October 15 2025. Its shares were up 3.9% at 0723 GMT, but down 37.5% year-to-date.
Reuters
10-07-2025
- Business
- Reuters
Gerresheimer cuts its 2025 revenue outlook for second time
July 10 (Reuters) - German packaging and medical equipment maker Gerresheimer ( opens new tab cut its revenue guidance for 2025 for a second time on Thursday, seeing continued weak demand in the cosmetic and oral liquids markets. It cut the lower end of its revenue growth forecast, now estimating a range of 0% to 2% growth in 2025, down from the previous range of 1-2%. "Growth momentum in the first half of the year overall was below our expectations," Dietmar Siemssen, CEO of Gerresheimer, said in a statement. While strong demand in drug delivery systems helped offset temporary market weakness for plastic containment solutions for oral liquids, boosting its plastics and devices business, its packaging glass business was hit by lower demand in moulded glass for cosmetics and in the market for oral liquids. The moulded glass business, which produces glass packaging for the food and beverage and cosmetic industry, is seen to be reducing growth, margins and returns, analysts at J.P. Morgan said in a research note. Following Gerresheimer's previous guidance cut in June, activist Asset Value Investor published an open letter in which it urged the company to take steps to improve its business. Those steps included potentially divesting its moulded glass business, a move supported by two other top 30 investors. Gerresheimer on Thursday confirmed its outlook for an adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) margin of around 20%, as it expects a stronger second half of the year. The medical packaging maker also cut its mid-term guidance, now expecting revenue growth in a range of 6-9%, down from a previous range of 8-10%, based on its outlook for 2025 and a stronger focus on cash flow, which led it to revise its investment planning.
Yahoo
10-07-2025
- Business
- Yahoo
Gerresheimer cuts its 2025 revenue outlook for second time
(Reuters) -German packaging and medical equipment maker Gerresheimer cut its revenue guidance for 2025 for a second time on Thursday, seeing continued weak demand in the cosmetic and oral liquids markets. It cut the lower end of its revenue growth forecast, now estimating a range of 0% to 2% growth in 2025, down from the previous range of 1-2%. "Growth momentum in the first half of the year overall was below our expectations," Dietmar Siemssen, CEO of Gerresheimer, said in a statement. However, it confirmed its outlook for an adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) margin of around 20%, as it expects a stronger second half of the year. The medical packaging maker also cut its mid-term guidance, now expecting revenue growth in a range of 6-9%, down from a previous range of 8-10%, based on its outlook for 2025 and a stronger focus on cash flow, which led it to revise its investment planning. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
